Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05534126 · ClinicalTrials.gov registry record · NA

Enhancing Cognitive Processing Therapy for Posttraumatic Stress Disorder Via Stellate Ganglion Block Treatment: A Pilot Trial

A NA study of Chronic Pain and Posttraumatic Stress Disorder, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05534126 is a NA study of Chronic Pain and Posttraumatic Stress Disorder that has completed, run by Rush University Medical Center. The registered enrollment target is 60 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05534126, a NA study of Chronic Pain and Posttraumatic Stress Disorder, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Cognitive Processing Therapy (CPT) is an effective first-line, evidence-based treatment for posttraumatic stress disorder (PTSD). Despite its well-demonstrated effectiveness, research has shown that approximately two-thirds of individuals continue to meet the diagnostic criteria for PTSD even after successful treatment completion. Stellate Ganglion Block (SGB) treatment, involving a local anesthesia injection to the stellate ganglion (around the lower base of the neck), has been shown to block its pain signal transmissions. Prior case studies and reviews have provided evidence for reducing PTSD symptoms with SGB treatment. However, studies to date have only examined SGB as a standalone intervention. The utility of combining CPT with concurrent SGB treatment remains unknown, although it is plausible that the combination of the two treatments can improve the effectiveness of CPT alone. The present study aims to test this hypothesis by comparing either a combined 1-week massed CPT + SGB treatment and 1-week massed CPT + placebo treatment (saline injection) using a randomized controlled trial design.

Interventions

  • PROCEDURE Placebo
  • PROCEDURE Stellate Ganglion Block Treatment

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-11-01
Est. Completion 2025-09-30
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT05534126

The ClinicalTrials.gov registry entry for NCT05534126 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05534126 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05534126 about?

NCT05534126 is a clinical study titled "Enhancing Cognitive Processing Therapy for Posttraumatic Stress Disorder Via Stellate Ganglion Block Treatment: A Pilot Trial". Cognitive Processing Therapy (CPT) is an effective first-line, evidence-based treatment for posttraumatic stress disorder (PTSD). Despite its well-demonstrated effectiveness, research has shown that approximately two-thirds of individuals continue to meet the diagnostic criteria for PTSD even after ...

What is the current status of trial NCT05534126?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-11-01. Estimated completion is 2025-09-30.

What conditions does trial NCT05534126 study?

This clinical trial studies the following conditions: Chronic Pain, Posttraumatic Stress Disorder.

What interventions are being tested in trial NCT05534126?

The interventions under investigation include: Placebo (PROCEDURE), Stellate Ganglion Block Treatment (PROCEDURE).

Who is sponsoring clinical trial NCT05534126?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05534126 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.